Alcon Research
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Alcon Research sits in the top decile of US sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count).
Alcon Research: 275 sponsored US clinical trials, 5 recruiting.
Alcon Research sponsors 275 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 248 completed. 87 of these trials are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract, with 12 trials.
Top-decile sponsor footprint
Alcon Research ranks in the top decile of sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
248 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
275 total, page 4 of 6
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
NCT01027494
Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution
NCT01341977
Effect of an Investigational Multi-Purpose Solution on Lens Moisture
NCT01341990
Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal Epithelium
NCT00724269
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
NCT00979615
ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)
NCT00967473
Clinical Evaluation of the Causes of Contact Lens Related Dry Eye
NCT00995189
Presbyopia-Correcting Intraocular Lenses (IOLs)
NCT00963560
Macular Edema Incidence/Severity Reduction With Nevanac
NCT00939276
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
NCT00845195
Circadian Ocular Perfusion Pressure and Ocular Blood Flow
NCT00800540
Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery
NCT00818844
Assessment of Visual Performance in Patients With Low Levels of Astigmatism
NCT00842231
Corneal Astigmatism Measurement Study
NCT00818532
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
NCT00818116
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
NCT00788541
Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients
NCT00799422
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
NCT00789555
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
NCT00772304
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment
NCT00798577
Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1
NCT00710931
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
NCT00794144
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
NCT00772707
Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery
NCT00870103
Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops
NCT00756093
Phaco Versus Small Incision Cataract Surgery (SICS) Health Economic Study
NCT00762606
Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green
NCT00768898
Acute Comfort and Blur of Systane Ultra and Systane
NCT00748865
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00691717
Evaluation of SYSTANE Ultra Lubricant Eye Drops
NCT00702377
Tobramycin Tear Concentrations
NCT00695435
Acute Comfort of Lubricant Eye Drops FID 112903
NCT00673855
Rotational Stability of the AcrySof® Toric
NCT00762216
Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial
NCT00691665
To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.
NCT00763360
The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance
NCT00673764
Comparison of 3 Novel Contact Lens Solutions on the Basal Lamina
NCT00691457
Evaluation of Deposits on Contact Lenses Worn Extended Wear
NCT00725530
Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)
NCT00691639
Evaluation of Deposits on Contact Lenses Worn Daily Wear
NCT00725153
24 Hour IOP Lowering Efficacy of AL-3789
NCT00643669
Blue Light Intraocular Lenses (IOLs) and Photostress
NCT00710996
Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)
NCT00733291
The Natural History of Geographic Atrophy Progression (GAP) Study
NCT00599846
A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
NCT00579020
Adjunctive Study of AL-37807 Ophthalmic Suspension
NCT00620256
Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL
NCT00934622
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
NCT00576251
Wettability of Contact Lenses With a Multi-Purpose Solution
NCT00713076
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
NCT00759941
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 23 |
| Phase 3 | 47 |
| Phase 4 | 40 |
Therapeutic Areas
Where Alcon Research enrollment is open (later-stage tilt)
5 recruiting of 275 indexed (2% open); 248 completed (90%).
Phase mix: 87 late (III/IV) vs 28 early (I/II) (later-stage heavy).
Top condition: Cataract (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alcon Research: open-pipeline peers nationwide
Peers matched on 275 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Alcon Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 275 trials (± recruiting share)
- Boston Scientific Corporation · 280 trials · 8% recruiting
- Regeneron Pharmaceuticals · 280 trials · 22% recruiting
- SWOG Cancer Research Network · 270 trials · 10% recruiting
- Novartis · 265 trials · 0% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · 2% recruiting · 55 trials
- Lexicon Pharmaceuticals · 2% recruiting · 56 trials
- Société des Produits Nestlé (SPN) · 2% recruiting · 53 trials
- Eisai · 2% recruiting · 287 trials
Related
What to do with this Alcon Research page
275 registered trials is a research-attention snapshot, not an endorsement of Alcon Research or any single study.
- 5 of Alcon Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cataract is the condition Alcon Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Alcon Research pipeline card: 275 registered trials from official public datasets.Report a data error.